Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 241 AL 255

Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease

Sodhi RK, Singh N, Jaggi AS.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Aug;384(2):115-24. doi: 10.1007/s00210-011-0654-6. Epub 2011 May 24.

The ethics of informed consent in Alzheimer disease research

Kim SY.

Nat Rev Neurol. 2011 May 24;7(7):410-4. doi: 10.1038/nrneurol.2011.76.

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

Farlow M, Veloso F, Moline M, Yardley J, Brand-Schieber E, Bibbiani F, Zou H, Hsu T, Satlin A.

BMC Neurol. 2011 May 25;11:57. doi: 10.1186/1471-2377-11-57.

Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration

Winton MJ, Lee EB, Sun E, Wong MM, Leight S, Zhang B, Trojanowski JQ, Lee VM.

J Neurosci. 2011 May 25;31(21):7691-9. doi: 10.1523/JNEUROSCI.6637-10.2011.

Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy

Lee S, Sato Y, Nixon RA.

J Neurosci. 2011 May 25;31(21):7817-30. doi: 10.1523/JNEUROSCI.6412-10.2011.

Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits

Sotiropoulos I, Catania C, Pinto LG, Silva R, Pollerberg GE, Takashima A, Sousa N, Almeida OF.

J Neurosci. 2011 May 25;31(21):7840-7. doi: 10.1523/JNEUROSCI.0730-11.2011.

Combined administration of D-galactose and aluminium induces Alzheimer-like lesions in brain

Xiao F, Li XG, Zhang XY, Hou JD, Lin LF, Gao Q, Luo HM.

Neurosci Bull. 2011 Jun;27(3):143-55. doi: 10.1007/s12264-011-1028-2.

Transdermal rivastigmine: management of cutaneous adverse events and review of the literature

Greenspoon J, Herrmann N, Adam DN.

CNS Drugs. 2011 Jul;25(7):575-83. doi: 10.2165/11592230-000000000-00000.

AMP-activated protein kinase: a potential player in Alzheimer's disease

Salminen A, Kaarniranta K, Haapasalo A, Soininen H, Hiltunen M.

J Neurochem. 2011 Aug;118(4):460-74. doi: 10.1111/j.1471-4159.2011.07331.x. Epub 2011 Jun 24.

Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent

Lister-James J, Pontecorvo MJ, Clark C, Joshi AD, Mintun MA, Zhang W, Lim N, Zhuang Z, Golding G, Choi SR, Benedum TE, Kennedy P, Hefti F, Carpenter AP, Kung HF, Skovronsky DM.

Semin Nucl Med. 2011 Jul;41(4):300-4. doi: 10.1053/j.semnuclmed.2011.03.001.

Cell cycle deregulation in the neurons of Alzheimer's disease

Moh C, Kubiak JZ, Bajic VP, Zhu X, Smith MA, Lee HG.

Results Probl Cell Differ. 2011;53:565-76. doi: 10.1007/978-3-642-19065-0_23.

A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model

Capsoni S, Brandi R, Arisi I, D'Onofrio M, Cattaneo A.

CNS Neurol Disord Drug Targets. 2011 Aug;10(5):635-47. doi: 10.2174/187152711796235032.

Alzheimer's disease: β-amyloid plaque formation in human brain

Seeman P, Seeman N.

Synapse. 2011 Dec;65(12):1289-97. doi: 10.1002/syn.20957.

Are tangles as toxic as they look?

Spires-Jones TL, Kopeikina KJ, Koffie RM, de Calignon A, Hyman BT.

J Mol Neurosci. 2011 Nov;45(3):438-44. doi: 10.1007/s12031-011-9566-7. Epub 2011 Jun 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias